Filing Details
- Accession Number:
- 0001140361-10-042421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-27 16:30:35
- Reporting Period:
- 2010-10-26
- Filing Date:
- 2010-10-27
- Accepted Time:
- 2010-10-27 16:30:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1461612 | M Daniel Bollag | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Sr. Vp, Reg. Affairs & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-10-26 | 3,000 | $3.70 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were purchased in a public offering of 16 million shares of ARIAD common stock priced on 10/26/2010 and closing on 10/29/2010.
Billionaire Hedge Funds
